该研究旨在对欧洲弱势妇女增加宫颈癌筛查率的干预成本效益研究进行系统回顾。在Embase、Medline、Global Health、PsychINFO和NHS经济评估数据库中，搜集了截至2022年9月的2000年1月至2022年9月发表的研究。研究符合以下条件：分析欧洲国家中各年龄段适合参与宫颈癌筛查的弱势妇女参与率的任何干预措施的成本效益，语言不限。总结研究特征和成本效益结果。使用Drummond检查表评估研究质量，并进一步比较方法选择。 检索共得到962篇独特研究，其中17篇（来自12个欧洲国家）符合数据提取的条件。所有研究都着重于欠筛查的妇女作为一个总体群体，未发现有研究专注于特定亚组的弱势妇女。一般而言，自行进行HPV测试和提醒干预措施被证明是提高参与率的经济有效措施。也有研究表明，在某些情况下解决接入问题和采用不同的筛查方式可能具有经济吸引力，但由于研究数量有限，目前的证据还不足够。 这项系统回顾揭示了关于针对特定群体的弱势妇女进行定制提供以提高宫颈癌筛查参与率干预措施的成本效益的文献缺口。© 2023作者。

This study aimed to conduct a systematic review of the cost-effectiveness studies of interventions to increase cervical cancer screening uptake rates in underserved women in Europe.A search of Embase, Medline, Global Health, PsychINFO, and NHS Economic Evaluation Database was conducted for studies published between January 2000 and September 2022. Studies were eligible if they analysed the cost-effectiveness of any interventions to improve participation in cervical cancer screening among underserved women of any age eligible to participate in cervical cancer screening in European countries, in any language. Study characteristics and cost-effectiveness results were summarised. Study quality was assessed using the Drummond Checklist, and methodological choices were further compared.The searches yielded 962 unique studies, with 17 of these (from twelve European countries) meeting the eligibility criteria for data extraction. All studies focused on underscreened women as an overarching group, with no identified studies focusing on specific subgroups of underserved women. Generally, self-HPV testing and reminder interventions were shown to be cost-effective to increase the uptake rates. There was also research showing that addressing access issues and adopting different screening modalities could be economically attractive in some settings, but the current evidence is insufficient due to the limited number of studies.This systematic review has revealed a gap in the literature on the cost-effectiveness of interventions to improve uptake rates of cervical cancer screening through tailored provision for specific groups of underserved women.© 2023. The Author(s).